Hepion Pharmaceuticals, Inc.
HEPA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583771
In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Other share classesCTRVP
13F holders, Q2 2022
Institutional positions in Hepion Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −4 vs. Q1 2022
- Shares held
- 7.41M
- −147.1K (−1.9%) vs. Q1 2022
- Total value
- $4.24M
- −$5.50M (−56.5%) vs. Q1 2022
- New holders
- 2
- 9 more added
- Sold out
- 6
- 9 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HEPA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 4 | $1.39K |
| Q1 2025 | 16 | $419.7K |
| Q4 2024 | 22 | $215.4K |
| Q3 2024 | 22 | $338.2K |
| Q2 2024 | 24 | $863.9K |
| Q1 2024 | 25 | $1.77M |
| Q4 2023 | 24 | $2.42M |
| Q3 2023 | 24 | $4.00M |
| Q2 2023 | 23 | $5.43M |
| Q1 2023 | 32 | $5.60M |
| Q4 2022 | 32 | $2.20M |
| Q3 2022 | 32 | $3.61M |
| Q2 2022 | 34 | $4.24M |
| Q1 2022 | 38 | $9.74M |
| Q4 2021 | 43 | $9.00M |
| Q3 2021 | 42 | $11.9M |
| Q2 2021 | 49 | $21.3M |
| Q1 2021 | 45 | $14.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Hepion Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 510 | $0 | 0.00% | +41+8.7% | Added |
| Bank of America Corp | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 309 | $0 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 1,001 | $1.00K | 0.00% | −3,500−77.8% | Reduced |
| Credit Suisse AG | 1,770 | $1.00K | 0.00% | +1,770 | New |
| Geneos Wealth Management Inc. | 5,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 3,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 10,090 | $5.00K | 0.00% | +89+0.9% | Added |
| Amplius Wealth Advisors, LLC | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11,648 | $7.00K | 0.00% | +9,768+519.6% | Added |
| Virtu Financial LLC | 22,935 | $13.0K | 0.00% | +22,935 | New |
| Advisor Group Holdings, Inc. | 24,766 | $14.0K | 0.00% | +1,777+7.7% | Added |
| Group One Trading, L.P. | 25,536 | $15.0K | 0.00% | −22,367−46.7% | Reduced |
| Morgan Stanley | 25,640 | $15.0K | 0.00% | −11,923−31.7% | Reduced |
| Charles Schwab Investment Management Inc | 31,535 | $19.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 40,445 | $23.0K | 0.00% | +17,024+72.7% | Added |
| Two Sigma Advisers, LP | 45,800 | $26.0K | 0.00% | −36,100−44.1% | Reduced |
| Boothbay Fund Management, LLC | 45,108 | $26.0K | 0.00% | −10,491−18.9% | Reduced |
| The PNC Financial Services Group, Inc. | 57,534 | $33.0K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 60,054 | $34.0K | 0.00% | +2,276+3.9% | Added |
| McAdam, LLC | 62,169 | $36.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 93,769 | $54.0K | 0.00% | +44,270+89.4% | Added |
| Northern Trust Corp | 133,264 | $77.0K | 0.00% | −8,940−6.3% | Reduced |
| Bank of New York Mellon Corp | 158,217 | $91.0K | 0.00% | −177−0.1% | Reduced |
| Renaissance Technologies LLC | 234,600 | $134.0K | 0.00% | +108,000+85.3% | Added |
| State Street Corp | 313,500 | $179.0K | 0.00% | −35,410−10.1% | Reduced |
| Ikarian Capital, LLC | 410,189 | $235.0K | 0.10% | −171,948−29.5% | Reduced |
| Geode Capital Management, LLC | 658,110 | $376.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,614,716 | $924.0K | 0.00% | +2,089+0.1% | Added |
| Vanguard Group Inc | 3,308,523 | $1.89M | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1 | – | – | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −14,956−100.0% | Sold out |
| JGP Wealth Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,453−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,845−100.0% | Sold out |